122 related articles for article (PubMed ID: 2468300)
1. Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease.
Ernst E; Matrai A; Kollar L
Angiology; 1989 May; 40(5):479-83. PubMed ID: 2468300
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease.
Ernst E; Matrai A; Kollar L
Lancet; 1987 Jun; 1(8548):1449-51. PubMed ID: 2885450
[TBL] [Abstract][Full Text] [Related]
3. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
5. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
[TBL] [Abstract][Full Text] [Related]
6. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
Kiesewetter H; Blume J; Jung F; Spitzer S; Wenzel E
J Intern Med; 1990 Feb; 227(2):107-14. PubMed ID: 1688914
[TBL] [Abstract][Full Text] [Related]
7. [Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Dtsch Med Wochenschr; 1986 Aug; 111(35):1307-12. PubMed ID: 2427301
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
[TBL] [Abstract][Full Text] [Related]
9. A double-blind trial of Dextran-haemodilution vs. placebo in claudicants.
Ernst E; Kollar L; Matrai A
J Intern Med; 1990 Jan; 227(1):19-24. PubMed ID: 1688913
[TBL] [Abstract][Full Text] [Related]
10. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
[TBL] [Abstract][Full Text] [Related]
11. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
12. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
13. [Bag plasmapheresis in patients with stage IIb peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Spitzer S; Leipnitz G; Wenzel E
Klin Wochenschr; 1988 Apr; 66(7):284-91. PubMed ID: 2453705
[TBL] [Abstract][Full Text] [Related]
14. Current therapy of peripheral obstructive arterial disease. The non-surgical approach.
De Felice M; Gallo P; Masotti G
Angiology; 1990 Jan; 41(1):1-11. PubMed ID: 2407152
[TBL] [Abstract][Full Text] [Related]
15. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
[TBL] [Abstract][Full Text] [Related]
16. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
17. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
Kiesewetter H; Blume J; Bulling B; Gerhards M; Jung F; Radtke H; Franke RP
Dtsch Med Wochenschr; 1984 Nov; 109(48):1844-7. PubMed ID: 6209081
[TBL] [Abstract][Full Text] [Related]
18. Reversal of acute renal failure using hemodilution with hydroxyethyl starch.
Rajagopalan PR; Reines HD; Pulliam C; Fitts CT; LeVeen HH
J Trauma; 1983 Sep; 23(9):795-800. PubMed ID: 6194306
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutical approaches to decreasing hematocrit and increasing claudication distance in diabetic patients with peripheral vascular disease.
Urge J; Strojil J; Utíkal P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):267-70. PubMed ID: 16601768
[TBL] [Abstract][Full Text] [Related]
20. Hematocrit dependent changes of muscle tissue oxygen supply in the lower limb muscle of patients with intermittent claudication.
Höffkes HG; Ehrly AM
Vasa; 1992; 21(4):350-4. PubMed ID: 1485467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
